A 26-week randomized controlled trial of semaglutide once daily versus liraglutide and placebo in patients with type 2 diabetes suboptimally controlled on diet and exercise with or without metformin

Ildiko Lingvay, Cyrus V. Desouza, Katarina S. Lalic, Ludger Rose, Thomas Hansen, Jeppe Zacho, Thomas R. Pieber

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint Dive into the research topics of 'A 26-week randomized controlled trial of semaglutide once daily versus liraglutide and placebo in patients with type 2 diabetes suboptimally controlled on diet and exercise with or without metformin'. Together they form a unique fingerprint.

Medicine & Life Sciences